Dr Ramón Iglesias-Rey | neuroimaging | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr Ramón Iglesias-Rey | neuroimaging | Best Researcher Award 🏆

  Miguel Servet Researcher at Health Research Institute of Santiago de Compostela (IDIS), Spain 🎓

Dr. Ramón Iglesias Rey is a Miguel Servet Researcher at the Fundación IDIS in Spain. He leads the preclinical Magnetic Resonance Unit within the Neuroimaging and Biotechnology Laboratory. His research focuses on the molecular mechanisms of disease using animal models and bioinstrumentation. He co-founded the spin-off company, LINCbiotech, in 2017.

Professional Profile 

🎓 Education

He earned a PhD in Materials Science (2013) and a Physics degree (2006) from the University of Santiago de Compostela.

🏢 Work Experience

Dr. Iglesias has served as a postdoc and research assistant at the University of Santiago and held an international postdoctoral position in Finland (2015).

🧬 Skills

He is skilled in molecular biology, MRI, and bioinstrumentation.

Awards and Honors 🏆

He has multiple patents and co-developed the “Glutamate nanoprobe MR-agent.”

📚 Teaching Experience

Involved in mentoring students in neuroscience and bioengineering.

 

🔬 Research Focus

Dr. Lozupone’s research primarily revolves around Alzheimer’s disease, cognitive frailty, and psychiatric conditions in the elderly. She has published extensively on neurodegenerative diseases, exploring topics such as tau-based therapeutics, antidepressant treatment in dementia, and the genetic factors influencing cognitive disorders. Her multidisciplinary research aims to improve diagnostics, therapeutic interventions, and patient outcomes in cognitive aging.

Conclusion 

Dr. Madia Lozupone is an outstanding candidate for the Cognitive Aging Excellence Award due to her extensive research contributions in Alzheimer’s disease, cognitive frailty, and late-life psychiatric disorders. Her leadership roles in several high-profile research projects, combined with her international editorial positions, make her a leader in the field of cognitive aging. By continuing to expand her collaborative research efforts and increasing her public engagement, Dr. Lozupone could further solidify her position as a top expert in cognitive aging.

📚 Publilcation 

  • Assessment of Mannitol-Induced Chronic Blood–Brain Barrier Dysfunction In Vivo Using Magnetic Resonance
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • Precision Medicine for Blood Glutamate Grabbing in Ischemic Stroke
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • C-Reactive Protein, Interleukin-6, and Vascular Recurrence According to Stroke Subtype
    • Year: 2024
    • Journal: Neurology
  • Edoxaban Treatment in a Post-Infarction Experimental Model
    • Year: 2024
    • Journal: European Journal of Pharmacology
  • How Can Radiomics Help the Clinical Management of Patients with Acute Ischemic Stroke?
    • Year: 2023
    • Journal: Applied Sciences
  • Influence of Temperature Chronobiology on Stroke Outcome
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
  • Fibrin-Targeted Nanoparticles for Finding, Visualizing, and Characterizing Blood Clots in Acute Ischemic Stroke
    • Year: 2022
    • Journal: Pharmaceutics
  • Need for a Paradigm Shift in the Treatment of Ischemic Stroke: The Blood-Brain Barrier
    • Year: 2022
    • Journal: International Journal of Molecular Sciences
  • Stress Granules and Acute Ischemic Stroke: Beyond mRNA Translation
    • Year: 2022
    • Journal: International Journal of Molecular Sciences
  • Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke
    • Year: 2022
    • Journal: Journal of Clinical Medicine

Dr. Amira Boseila | Neuroscience| Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Amira Boseila | Neuroscience| Best Researcher Award🏆


Lecturer at Sinai University,Egypt🎓

Dr. Amira Abdel Halim Hamada Boseila is a full-time lecturer in Pharmaceutical Sciences at Sinai University, Egypt, where she teaches advanced courses in drug delivery systems and pharmaceutics. She also serves as a post-doctoral researcher at the National Organization for Drug Control and Research (NODCAR) and the Egyptian Drug Authority. With a PhD from Cairo University, her research focuses on nanomedicine, drug targeting, and innovative drug delivery systems. Dr. Boseila has contributed to several impactful publications and is actively involved in various research projects aimed at enhancing therapeutic strategies.

 

Professional Profile 

🎓 Education

Dr. Amira Abdel Halim Hamada Boseila holds a Doctor of Philosophy in Pharmaceutical Sciences from the Faculty of Pharmacy at Cairo University, awarded in February 2020, with a thesis focused on the utility of nanocarriers for targeted delivery of an antiviral drug to the liver. She also earned a Master of Pharmaceutical Sciences from Cairo University in December 2013, where her thesis was centered on the formulation and evaluation of a modified nasal drug delivery system for the antiemetic drug ondansetron. Additionally, she completed a Total Quality Management Diploma at the American University of Cairo in 2009, further enhancing her expertise in quality control management. Her academic journey began with a Bachelor of Pharmaceutical Sciences from Cairo University, graduating in May 2007 with a grade of very good. She attended La Rose De Lisieux/Language School in Dokkie, where she completed her high school education with a focus on science from September 1990 to June 2002.

 

🏢 Work Experience

Full-time lecturer at the Faculty of Pharmacy, Sinai University since September 2022, and post-doctoral researcher at NODCAR and the Egyptian Drug Authority since July 2020. Previously held positions as lead quality control specialist and head of the Comparative Dissolution Unit. Guest lecturer on drug targeting at Ain Shams University since October 2020

🧬 Skills

Expertise in novel drug delivery systems, nanomedicine, drug targeting, pharmacokinetics, comparative dissolution studies, and quality by design

Awards and Honors 🏆

Recognized for contributions to pharmaceutical research through impactful publications and ongoing collaborations with prestigious institutions, including funded research projects from the University of Hail and Misr El Kheir Foundation

🔬 Research Focus

Dedicated to advancing nanomedicine and innovative drug delivery systems, with a focus on developing targeted therapies and modified release dosage forms. Actively involved in projects aimed at repurposing anti-inflammatory agents and formulating virucidal throat sprays

📚 Publication 

  • Impact of Lyophilized Milk Kefir-Based Self-Nanoemulsifying System on Cognitive Enhancement via the Microbiota–Gut–Brain Axis
    Author: Amira Boseila
    Citation: MDPI, 2023
  • Throat Spray Formulated with Virucidal Pharmaceutical Excipients as an Effective Early Prophylactic or Treatment Strategy Against Pharyngitis Post-Exposure to SARS-CoV-2
    Author: Amira Boseila
    Citation: ScienceDirect, 2024
  • Antidepressive and Cardioprotective Effects of Self-Nanoemulsifying Self-Nanosuspension Loaded with Hypericum Perforatum on Post-Myocardial Infarction Depression in Rats
    Author: Amira Boseila
    Citation: Springer, 2022
  • Recent Advances in Adsorptive Nanocomposite Membranes for Heavy Metals Ion Removal from Contaminated Water: A Comprehensive Review
    Author: Amira Boseila
    Citation: MDPI, 2023
  • Iron Oxide Nanoparticles-Plant Insignia Synthesis with Favorable Biomedical Activities and Less Toxicity, in the “Era of the-Green”: A Systematic Review
    Author: Amira Boseila
    Citation: NIH, 2023
  • In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity
    Author: Amira Boseila
    Citation: PubMed, 2023
  • Superiority of DEAE-Dx-Stabilized Cationic Bile-Based Vesicles over Conventional Vesicles for Enhanced Hepatic Delivery of Daclatasvir
    Author: Amira Boseila
    Citation: Molecular Pharmaceutics, 2023
  • Design of Bile-Based Vesicles (BBVs) for Hepatocytes Specific Delivery of Daclatasvir: Comparison of Ex-Vivo Transenterocytic Transport, In-Vitro Protein Adsorption Resistance, and HepG2 Cellular Uptake of Charged and β-Sitosterol Decorated Vesicles
    Author: Amira Boseila
    Citation: PubMed, 2023
  • Preparation and Characterization of Thermosensitive Mucoadhesive In-Situ Gels for Nasal Delivery of Ondansetron Hydrochloride
    Authors: A.A. Boseila, A.Y. Abdel-Reheem, G. Abdelbary
    Citation: Al-Azhar Journal of Pharmaceutical Sciences, 2014

 

Prof Dr. BASSEMSADEK | Neuropharmacology | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof Dr. BASSEMSADEK | Neuropharmacology | Best Researcher Award 🏆

Pharmacology and Therapeutics at College of Medicine and Health Sciences, United Arab Emirates University🎓

Dr. Bassem Shaban Sadek is a highly accomplished professor specializing in Pharmaceutical Medicinal Chemistry and Neuropharmacology. He is currently a Full Professor in the Department of Pharmacology and Therapeutics at the United Arab Emirates University, with ongoing research collaborations in Germany. His career spans over two decades of academic, research, and professional experience in both Europe and the Middle East.

Professional Profile 

Education

Dr. Sadek earned his Ph.D. in Pharmaceutical Medicinal Chemistry and Drug Design in 1999 from the Free University of Berlin (FUB), where his thesis focused on the development of selective and potent Histamine H3-Receptor Antagonists. He also holds a Bachelor of Pharmacy, which he received in 1994 from FUB.

 Work Experience

Throughout his career, Dr. Sadek has held various academic positions, starting as a Teaching Assistant at the Free University of Berlin, progressing to Assistant Professor roles at universities in the UAE and Germany. Notably, he was the Director of the Pharm-D Program at UAE University from 2015 to 2019. Since 2021, he has been a Full Professor at UAE University and a Research Associate at Heinrich Heine University in Düsseldorf, Germany.

 Skills 

Dr. Sadek has advanced expertise in preclinical research design and medical statistical analysis. He is proficient in statistical software like SPSS and GraphPad Prism, as well as molecular modeling tools such as ChemDraw, MOE, PyMol, and drug-likeness prediction programs. His knowledge extends to data analysis and visualization using Excel and PowerPoint.

Awards & Honors

Dr. Sadek has received numerous prestigious awards, including multiple Distinguished Research Awards for publishing in top international journals, Best Teacher Awards, and the ADEK Award for Research Excellence. His teaching and research have been recognized for excellence in both undergraduate and postgraduate education.

 Membership

He is actively involved in several professional bodies, including the Society for Neuroscience (SfN), the European Histamine Research Society (EHRS), and the German Pharmaceutical Association (DPhG). He also serves on editorial boards for various scientific journals and as a reviewer for major international funding bodies.

 

 Teaching Experience

Dr. Sadek has extensive teaching experience, offering courses in neuropharmacology, pharmacokinetics, and drug design for both undergraduate and postgraduate students. He has supervised numerous graduate theses and research projects, contributing to the academic development of his students.

 Research Focus

His research centers on preclinical drug development targeting neurodegenerative and behavioral disorders. He specializes in histamine H3 receptor antagonists, exploring their potential in treating conditions such as autism, epilepsy, and Alzheimer’s disease. Dr. Sadek employs cutting-edge in vivo and in vitro models to advance neuropharmacological research.

 

📖Publications : 

  • “Alleviation of Autophagic Deficits and Neuroinflammation by Histamine H3 Receptor Antagonist E159 Ameliorates Autism-Related Behaviors in BTBR Mice”
  • “The Microbiota–Gut–Brain Axis and Neurological Disorders: A Comprehensive Review”
  • “Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer’s Disease, Parkinson’s Disease, and Autism Spectrum Disorder”
  • “Apigenin Alleviates Autistic-like Stereotyped Repetitive Behaviors and Mitigates Brain Oxidative Stress in Mice”
  • “The Potent and Selective Histamine H3 Receptor Antagonist E169 Counteracts Cognitive Deficits and Mitigates Disturbances in the PI3K/AKT/GSK-3β Signaling Pathway in MK801-Induced Amnesia in Mice”
  • “Canagliflozin Ameliorates Oxidative Stress and Autistic-like Features in Valproic-Acid-Induced Autism in Rats: Comparison with Aripiprazole Action”
  • “Pharmacological and Molecular Insight on the Cardioprotective Role of Apigenin”
  • “Repurposing SGLT2 Inhibitors for Neurological Disorders: A Focus on the Autism Spectrum Disorder”
  • “Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of Autism”
  • “Role of Brain Modulators in Neurodevelopment: Focus on Autism Spectrum Disorder and Associated Comorbidities”

Assist Prof Dr. Farzad Nasiri | Clinical Psychology| Best Researcher Award

Published on by Cognitive Scientist Awards

 Assist Prof Dr. Farzad Nasiri | Clinical Psychology | Best Researcher Award  🏆

University of Kurdistan,IRAN 🎓

Dr. Farzad Nasiri is an Associate Professor at the University of Kurdistan, where he also serves as the Head of the Department of Psychology. With a rich background in clinical and experimental psychology, he has been dedicated to advancing both academic research and therapeutic practice. His professional journey is marked by a strong commitment to psychology and cognitive-behavioral therapy (CBT), particularly in the treatment of anxiety and mood disorders.

 

 

Professional Profile 

🎓 Education

Dr. Nasiri completed his Ph.D. in Psychology in 2019 at Ferdowsi University of Mashhad, following his Master’s (2012) and Bachelor’s degrees (2010) in Clinical Psychology from the University of Tabriz. His academic journey began with a High School Diploma in Experimental Sciences from Shaheed Beheshti School in 2004, highlighting his early dedication to scientific disciplines.

 

🏢 Work Experience

Dr. Nasiri has extensive experience as a university professor, teaching Ph.D., Master’s, and Bachelor’s courses in clinical psychology, cognitive psychology, neuropsychology, and psychotherapy techniques. In addition to his academic roles, he has been a reviewer and editor for various scientific journals, including the Journal of Clinical Psychology and Counseling and the Journal of Medical Sciences.

 

🧬 Skills

Dr. Nasiri’s expertise lies in Cognitive Behavioral Therapy (CBT) and transcranial direct current stimulation (tDCS). He has led workshops on anxiety management and tDCS, and his therapeutic focus centers on mood and anxiety disorders. His extensive research covers mindfulness-based therapies, emotional regulation, and executive functions in psychological disorders.

Awards and Honors 🏆

Throughout his career, Dr. Nasiri has earned exceptional grades, with notable recognition for his research and clinical work. His thesis projects earned the highest distinctions, including a perfect score of 20 for his Ph.D. dissertation under Dr. Ali Mashhadi.

 

🔬 Research Focus

Dr. Nasiri’s research spans cognitive and emotional indices of anxiety, transdiagnostic therapy, and mindfulness-based interventions. He has authored several books and translated works on CBT, chronic pain, insomnia, and autism. His scholarly publications address critical psychological issues, including anxiety disorders, resilience, and emotional regulation strategies.

 

📚 Publilcation 

  • Comparison of executive functions in people with high and low resilience
    Year: 2024 | Journal: Journal of Psychiatric Research
    (Shariati, A., Nasiri, F., Rahmani, F.)
  • A culturally adapted unified protocol for transdiagnostic treatment of anxiety disorders in adolescents (UP-A): A randomized waitlist-controlled trial
    Year: 2024 | Journal: Psychological Medicine
    (Zemestani, M., Ezzati, S., Nasiri, F., Barlow, D.H., Kendall, P.C.)
  • Augmenting the unified protocol with transcranial direct current stimulation: Effects on emotion regulation and executive dysfunction
    Year: 2023 | Journal: Clinical Psychology and Psychotherapy
    (Nasiri, F., Ellard, K.K., Mashhadi, A., Bigdeli, I., Ghanaei-Chamanabad, A.)
  • Premenstrual Syndrome: The Role of Emotion Regulation Strategies and Trait Meta-Mood
    Year: 2022 | Journal: Journal of Rational – Emotive and Cognitive – Behavior Therapy
    (Nasiri, F., Sharifi, S., Mashhadi, A., Sharp, R.)
  • How to Differentiate Generalized Anxiety Disorder from Worry: The Role of Cognitive Strategies
    Year: 2020 | Journal: Journal of Rational – Emotive and Cognitive – Behavior Therapy
    (Nasiri, F., Mashhadi, A., Bigdeli, I., Chamanabad, A.G.)
  • Augmenting the unified protocol for transdiagnostic treatment of emotional disorders with transcranial direct current stimulation in individuals with generalized anxiety disorder and comorbid depression: A randomized controlled trial
    Year: 2020 | Journal: Journal of Affective Disorders
    (Nasiri, F., Mashhadi, A., Bigdeli, I., Chamanabad, A.G., Ellard, K.K.)

 

 

Joanna Bartkowiak-Wieczorek | Pharmacology | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Joanna Bartkowiak-Wieczorek | Pharmacology | Best Researcher Award 🏆

Poznan University of Medical Sciences, Poland🎓

Dr.Joanna Bartkowiak-Wieczorek is an accomplished researcher and Assistant Professor at the Medical University of Karol Marcinkowski in Poznań, specializing in pharmacology and pharmacogenetics. With a strong focus on cannabinoids and their potential medical applications, particularly in oncology and personalized medicine, she has contributed significantly to understanding how genetic factors influence drug response. Joanna’s work has been recognized with the Best Researcher Award, reflecting her dedication to advancing pharmacological research and education. She is committed to bridging the gap between scientific inquiry and clinical practice, enhancing the safety and efficacy of pharmacotherapy for diverse patient populations.

 

Professional Profile 

 

🎓 Education

Joanna Bartkowiak-Wieczorek holds a Master of Science in Biological Sciences from Adam Mickiewicz University in Poznań, specializing in molecular biology. She completed her PhD at the Medical University of Poznań, focusing on epigenetic modifications in hybrids of green frogs and the polymorphism of genes associated with osteoporosis risk.

🏢 Work Experience

Since September 2018, she has served as an Assistant Professor at the Medical University of Karol Marcinkowski in Poznań, where she conducts research and teaches various programs in human physiology. Prior to this, she worked as scientific and technical staff at the Medical University of Poznań, conducting pharmacogenetic research and educational classes. She also held roles focused on quality management systems at the Institute of Natural Fibres and Medicinal Plants, contributing to the implementation of GMP and ISO standards.

 

Awards and Honors 🏆

Joanna has participated in various research projects funded by the National Science Centre, focusing on pharmacogenetics and the development of technologies for cannabinoid extraction for cancer treatment. Her contributions to scientific knowledge have been recognized through numerous publications in reputable journals, reflecting her commitment to advancing research in her field.

🔬 Research Focus

Joanna’s research primarily explores cannabinoids, their pharmacological properties, and applications in oncology and personalized medicine. She has conducted significant studies on the influence of individual genes on drug responses and has a strong background in pharmacogenetics, drug interactions, and the therapeutic potential of plant-based compounds.

Conclusion 

Joanna’s qualifications and achievements position her as a leading figure in her field, making her a suitable candidate for the Best Researcher Award. By addressing the identified areas for improvement, she could further enhance her research impact and continue to contribute to advancements in pharmacology and personalized medicine.

📚 Publilcation 

  1. Bartkowiak-Wieczorek, J., et al. (2024). Cannabis sativa L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat. Biomolecules. DOI: 10.3390/biom14091065
  2. Bartkowiak-Wieczorek, J., et al. (2024). Methylsulfinyl Hexyl Isothiocyanate (6-MSITC) from Wasabi: A Promising Candidate for Cancer, Alzheimer’s Disease, and Obesity Treatment. Nutrients. DOI: 10.3390/nu16152509
  3. Bartkowiak-Wieczorek, J., et al. (2024). The Dual Faces of Oestrogen: The Impact of Exogenous Oestrogen on Physiological and Pathophysiological Functions of Tissues and Organs. International Journal of Molecular Sciences. DOI: 10.3390/ijms25158167
  4. Bartkowiak-Wieczorek, J., et al. (2024). Natural Products and Health. Nutrients. DOI: 10.3390/nu16030415
  5. Bartkowiak-Wieczorek, J. (2023). A Critical Look at New Possibilities of Therapeutic Use of Statins: A Summary of Current Knowledge. Farmacja Polska. DOI: 10.32383/farmpol/174070
  6. Bartkowiak-Wieczorek, J., et al. (2023). THC-Reduced Cannabis sativa L.—How Does the Solvent Determine the Bioavailability of Cannabinoids Given Orally?. Nutrients. DOI: 10.3390/nu15122646
  7. Bartkowiak-Wieczorek, J., et al. (2022). The Dark Side of Iron: The Relationship Between Iron, Inflammation, and Gut Microbiota in Diseases Associated with Iron Deficiency Anaemia. Nutrients. DOI: 10.3390/nu14173478
  8. Bartkowiak-Wieczorek, J. (2022). Polygraph Analyses: Technical and Practical Background. Journal of Medical Science. DOI: 10.20883/medical.e590
  9. Bartkowiak-Wieczorek, J., et al. (2021). High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota: A Narrative Review. Cells. DOI: 10.3390/cells10113164
  10. Bartkowiak-Wieczorek, J., et al. (2020). Relationship Between Adipocytokines and Angiotensin-Converting Enzyme Gene Polymorphism in Lean Women with and without Polycystic Ovary Syndrome. Gynecological Endocrinology. DOI: 10.1080/09513590.2019.1695248
  11. Bartkowiak-Wieczorek, J., et al. (2020). Effect of Different Water Extracts from Platycodon grandiflorum on Pathogenesis of Chronic Bronchitis in Rats. Molecules. DOI: 10.3390/molecules25215020
  12. Bartkowiak-Wieczorek, J., et al. (2020). Effect of Genetic Variations for Interleukin-10 on Efficacy of Immunosuppressive Therapy in Kidney Transplant Patients. International Immunopharmacology. DOI: 10.1016/j.intimp.2020.107059
  13. Bartkowiak-Wieczorek, J. (2020). The MDR1/ABCB1 Gene Polymorphism in Colorectal Cancer. Archives of Medical Science. DOI: 10.5114/aoms.2017.70329
  14. Bartkowiak-Wieczorek, J., et al. (2019). Effect of MDR1 and CYP3A41B Polymorphisms on Cyclosporine-Based Immunosuppressive Therapy in Renal Transplant Patients*. Annals of Transplantation. DOI: 10.12659/AOT.914683
  15. Bartkowiak-Wieczorek, J. (2018). Demographic Factors Determining Folic Acid Supplementation in Pregnant and Childbearing-Age Women. Ginekologia Polska. DOI: 10.5603/GP.a2018.0036
  16. Bartkowiak-Wieczorek, J. (2018). Effect of Interleukin-6 Polymorphism on Renal Allograft Function and Immunosuppressive Therapy Efficacy. Farmacia. DOI: 10.31925/farmacia.2018.5.8
  17. Bartkowiak-Wieczorek, J., et al. (2018). Importance of New Generation Sequencing HLA Typing in Renal Transplantation—Preliminary Report. Transplantation Proceedings. DOI: 10.1016/j.transproceed.2018.05.005
  18. Bartkowiak-Wieczorek, J., et al. (2017). Effect of Salvia miltiorrhiza Root Extract on Brain Acetylcholinesterase, Butyrylcholinesterase Activities, mRNA Levels, and Memory in Rats. Physiology and Behavior. DOI: 10.1016/j.physbeh.2017.02.019
  19. Bartkowiak-Wieczorek, J. (2017). Role of the ITLN1 Gene Allelic Variant in Patients with Diabetic Foot. Polish Archives of Internal Medicine. DOI: 10.20452/pamw.4008
  20. Bartkowiak-Wieczorek, J., et al. (2017). Polymorphic Variants of Collagen 1A2 Gene in Osteopenia and Osteoporosis Development in Postmenopausal Women. Ginekologia Polska. DOI: 10.5603/GP.A2017.0077
  21. Bartkowiak-Wieczorek, J., et al. (2016). Analysis of Aldosterone Synthase and Atrial Natriuretic Peptide Gene Polymorphisms in Women with Preeclampsia. European Journal of Obstetrics and Gynecology and Reproductive Biology. DOI: 10.1016/j.ejogrb.2015.11.012
  22. Bartkowiak-Wieczorek, J. (2016). Association Between ACE Gene Polymorphism and Metabolic Disturbances in PCOS Women. Molecular Medicine Reports. DOI: 10.3892/mmr.2016.5910
  23. Bartkowiak-Wieczorek, J., et al. (2016). Influence of Melissa officinalis Leaf Extract on Long-Term Memory in Scopolamine Animal Model. Evidence-Based Complementary and Alternative Medicine. DOI: 10.1155/2016/9729818
  24. Bartkowiak-Wieczorek, J. (2016). Association Between Metabolic Syndrome Development in PCOS Patients and MTHFR Gene Polymorphism. Ginekologia Polska. DOI: 10.17772/gp/61751
  25. Bartkowiak-Wieczorek, J., et al. (2016). Antinociceptive and Anti-Inflammatory Effects of Oleanolic Acid and Aspirin Conjugate. Frontiers in Pharmacology. DOI: 10.3389/fphar.2016.00202
  26. Bartkowiak-Wieczorek, J. (2016). Importance of MDR1 Gene Polymorphisms in Colorectal Cancer Etiology. Przegląd Gastroenterologiczny. DOI: 10.5114/pg.2015.51185
  27. Bartkowiak-Wieczorek, J., et al. (2016). Influence of TNF-α Polymorphism on Immunosuppressive Therapy Efficacy in Kidney Transplant Patients. Journal of Physiology and Pharmacology.
  28. Bartkowiak-Wieczorek, J. (2016). Significance of Genetic Polymorphisms in the RANKL/RANK/OPG Signaling Pathway in Postmenopausal Osteoporosis. Ginekologia Polska. DOI: 10.5603/GP.2016.0014
  29. Bartkowiak-Wieczorek, J., et al. (2015). Analysis of ADIPOQ Gene Polymorphisms in Women with Excessive Weight Gain During Pregnancy. Ginekologia Polska. DOI: 10.17772/gp/2421
  30. Bartkowiak-Wieczorek, J., et al. (2015). Evaluation of Anti-Inflammatory and Analgesic Activities of Extracts from Chelidonium majus L. Herb. Central European Journal of Immunology. DOI: 10.5114/ceji.2015.54607
  31. Bartkowiak-Wieczorek, J. (2015). *Gender-Specific Implications for Pharmacology in Women of Child

 

Dr sandra zaouche | Microbiology | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr sandra zaouche | Microbiology | Best Researcher Award 🏆

Biotechnology at The Stephan Angeloff Institute of Microbiology-BAS,Bulgaria🎓

This individual is a Senior Assistant Professor specializing in Microbiology with extensive academic and research experience. They currently work at The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, in Sofia, Bulgaria. Their career spans over a decade, contributing to both research and teaching in microbiology and microbial biotechnology.

 

Professional Profile 

  • scopus

🎓 Education

They completed their PhD in Microbiology at The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences (2008-2013). Prior to this, they obtained an MSc in Microbial Biotechnology from Plovdiv University “Paisii Hilendarski” (2007) and a BSc in Biology and Chemistry from the same university (2005) 🎓📚.They completed their PhD in Microbiology at The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences (2008-2013). Prior to this, they obtained an MSc in Microbial Biotechnology from Plovdiv University “Paisii Hilendarski” (2007) and a BSc in Biology and Chemistry from the same university (2005) 🎓📚.

🏢 Work Experience

The individual has held several academic positions, starting as an Assistant Professor and advancing to Senior Assistant Professor at The Stephan Angeloff Institute of Microbiology (2012-present). Their role involves conducting cutting-edge research in microbiology, teaching students, and contributing to the academic community through various scholarly activities 🏫🔬.

🧬 Skills

Their expertise includes microbiological research, microbial biotechnology, laboratory management, and advanced research methodologies. They are proficient in designing experiments, analyzing data, and applying scientific principles to solve complex biological problems 🧪🔍.

Awards and Honors 🏆

Throughout their career, they have received multiple accolades for their contributions to the field of microbiology, reflecting their dedication to advancing scientific knowledge and their commitment to excellence in research and education 🏆✨

🔬 Professional Memberships

They are a member of several prestigious professional societies related to microbiology and biotechnology, staying actively engaged with the scientific community for the exchange of knowledge and innovation 🌐👩‍🔬.

📚 Teaching Experience

With years of experience teaching at the undergraduate and graduate levels, they have mentored and trained numerous students in microbiology and related fields, ensuring they provide a high standard of education and foster a collaborative learning environment 🧑‍🏫👩‍🎓.

🔬 Research Focus

Their primary research interest is in the field of microbial biotechnology, particularly focusing on the application of microorganisms in industrial processes, environmental sustainability, and the development of new biotechnological tools. They aim to explore innovative ways to harness the potential of microbes for solving global challenges 🌱🧬.

📚 Publilcation 

 

Dr Gamze Gök | biochemistry | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr Gamze Gök | biochemistry | Best Researcher Award 🏆

Medical biochemist at  Ankara Bilkent City Hospital, Turkey🎓

👩‍🔬 Gamze Gök is a dedicated Medical Biochemist, currently working in the Medical Biochemistry Department at Ankara Bilkent City Hospital, Turkey. Specializing in biochemistry, Gamze has a keen interest in oxidative stress, thiol-disulfide homeostasis, trace elements, and fatty acids. Her research spans across these fields, contributing significantly to the scientific community through numerous publications.

 

Professional Profile 

🎓 Education

🎓 Gamze completed her medical biochemistry specialization in 2021, gaining in-depth knowledge in biochemical processes. She is highly skilled in scientific research, having taken part in numerous national and international studies throughout her academic career.

🏢 Work Experience

🏥 Since completing her specialization, Gamze has been an active researcher at Ankara Bilkent City Hospital. She has played a critical role in 21 published studies on PubMed, covering various biochemistry-related topics and contributing significantly to advancements in medical science.

🧬 Skills

🧪 Core Skills include expertise in oxidative stress markers, thiol-disulfide homeostasis, and the analysis of trace elements and fatty acids. Gamze also excels in methodological approaches to research, formal analysis, and scientific writing. Her collaborative spirit and commitment to innovative biochemistry research are commendable.

Awards and Honors 🏆

🏅 Gamze has been recognized for her contributions to medical biochemistry, having been part of 25 journals indexed in prestigious databases such as SCI and Scopus. Her extensive research involvement has earned her notable mentions in several international forums.

🔬 Professional Memberships

Although Gamze does not currently hold memberships in any professional organizations, her extensive work in collaborative research projects speaks to her professional dedication and ongoing contributions to the medical biochemistry community.

📚 Teaching Experience

Gamze has demonstrated leadership through her mentorship in various research studies. Although not formally engaged in teaching roles, she has shared her knowledge through collaborative efforts and has contributed to the growth of research methodologies in the medical field.

🔬 Research Focus

Gamze’s research focus is on critical biochemical areas such as oxidative stress, thiol-disulfide homeostasis, and fatty acids. She has contributed to the study of glutathione’s role in the development and prognosis of non-muscle-invasive bladder cancer, among other significant biochemistry topics.

 

📚 Publilcation 

  • The Effect of Glutathione on Development and Prognosis in Non-Muscle-Invasive Bladder Cancer
    2024 – Journal of Clinical Medicine, 13(18), 5483
  • Evaluation of Ethanol Test Analysis: The Two Years Experience
    2024 – International Journal of Medical Biochemistry, 7(3), pp. 163–167
  • Assessment of Thiol-Disulfide and Glutathione Homeostasis After Levothyroxine Replacement in Individuals with Autoimmune or Nonautoimmune Hypothyroidism
    2024 – Archives of Endocrinology and Metabolism, 68, e230197
  • Evaluation of Drug Abuse Test Analysis: One Year Experience
    2024 – International Journal of Medical Biochemistry, 7(2), pp. 67–72
  • Evaluation of the Dynamic Thiol/Disulfide Homeostasis in Patients with Chronic Venous Insufficiency
    2024 – Journal of Vascular Surgery: Venous and Lymphatic Disorders, 12(1), 101689
  • Validation of Assays for Measurement of Oxidant Compounds in Saliva of Pigs: Thiobarbituric Acid Reactive Substances (TBARS), Carbonyl, and Reactive Oxygen Species (ROS)
    2023 – Research in Veterinary Science, 165, 105069
  • The Effects of Cerium Oxide on Sevoflurane Anesthesia and Its Relationship to Renal Injury in Rats
    2023 – Gazi Medical Journal, 34(3), pp. 283–287
  • The Relationship Between Vitamin-D Deficiency and Protein Oxidation Among Obese Children
    2023 – Fetal and Pediatric Pathology, 42(4), pp. 599–613
  • An Evaluation of Thiol/Disulphide Homeostasis and HDL Values in Patients with Cholelithiasis: A Prospective Case-control Study
    2022 – Journal of the College of Physicians and Surgeons Pakistan, 32(4), pp. 424–429
  • Is Dynamic Thiol/Disulphide Homeostasis Associated with the Prognosis of Geriatric Patients with Sepsis in the Intensive Care Unit?
    2022 – Turk Geriatri Dergisi, 25(4), pp. 495–503

 

Frederic Roche | Clinical Physiology | Best Researcher Award

Published on by Cognitive Scientist Awards

Frederic Roche | Clinical Physiology | Best Researcher Award  🏆

CHU saint Etienne, France🎓

Frederic Roche is a distinguished Professor of Clinical Physiology at University Hospital Saint-Etienne, born on June 15, 1965. 🎓 He earned his Master’s degree in Biology (Exercise Physiology) from UJM Saint Etienne in 1990, followed by an MD in Cardiology from Université Claude Bernard, Lyon 1, in 1995. He completed his PhD in Physiology, Pathophysiology, Exercise, and Handicap in 2002 and achieved his HDR from UJM Saint Etienne in 2009

Professional Profile 

🎓 Education

Frederic Roche’s educational journey is marked by a strong foundation in biology and medicine. He began his academic pursuit at the University Jean Monnet (UJM) in Saint Etienne, where he earned his Master’s degree in Biology, specializing in Exercise Physiology, in 1990. Following this, he continued to advance his studies in the medical field and received his Doctor of Medicine (MD) degree in Cardiology from Université Claude Bernard, Lyon 1, in 1995. Frederic’s commitment to research and academia led him to pursue a PhD in Physiology, Pathophysiology, Exercise, and Handicap at UJM Saint Etienne, which he completed in 2002. His academic excellence culminated in his Habilitation à Diriger des Recherches (HDR) in 2009, further solidifying his expertise and qualifications in the field of physiology. This comprehensive educational background has equipped Frederic with a robust understanding of clinical physiology and a profound capability to contribute to research and teaching in his specialized areas. 🎓

🏢 Work Experience

Frederic Roche has had an illustrious career in clinical physiology and cardiovascular health, holding key positions that showcase his expertise and leadership. From 2015 to 2022, he served as the Head of the Clinical Physiology Department at CHU Saint Etienne, where he led a team focused on advancing patient care and medical research in physiology. Prior to this, from 2011 to 2020, he was the Director of the Laboratory SNA EPIS Research Team at UJM Saint Etienne. In this role, he guided research initiatives on exercise physiology, cardiovascular function, and sleep medicine, contributing significantly to the understanding of these areas. 🏥 Frederic’s involvement extends to both national and international research projects, where he has been a principal investigator (PI) and co-investigator in numerous clinical studies, including several industrial phase III drug and medical device trials. His professional experience is backed by a strong publication record and extensive teaching, making him a key figure in clinical research and physiology. 📊

🧬 Skills

Frederic Roche possesses a diverse set of skills that make him a highly esteemed figure in the field of clinical physiology and cardiology. His expertise in exercise physiology and sleep medicine is backed by years of academic research and practical experience. He has a deep understanding of cardiovascular health, focusing on the physiological and pathophysiological aspects of diseases. His proficiency in conducting and leading clinical trials—ranging from national to industrial phase III drug and medical device studies—demonstrates his robust research capabilities. 📊 Frederic is also skilled in data analysis and scientific writing, having published over 220 papers in SCI-indexed journals. His ability to mentor and guide students through complex research projects showcases his mentorship and teaching strengths. Moreover, his leadership experience as the Head of Department and Director of a research laboratory highlights his skills in team management, collaboration, and strategic decision-making within academic and clinical settings. 🧠 His commitment to continuous learning and knowledge transfer is evident in his active involvement in research and training initiatives.

🏆 Awards and Honors

Frederic Roche has received numerous awards and honors throughout his esteemed career, reflecting his significant contributions to the fields of clinical physiology, cardiology, and sleep medicine. 🏆 He has been recognized for his pioneering research in exercise physiology and its impact on cardiovascular health, earning accolades for his innovative studies on obstructive sleep apnea and its effects on the heart. His leadership as the Director of the Laboratory SNA EPIS Research Team has also garnered attention, particularly for his work on understanding autonomic nervous system regulation in various health conditions. 🌟

🔬 Research Focus

Frederic Roche’s research focus primarily revolves around exercise physiology, cardiovascular health, and the interplay between sleep disorders and chronic diseases. His work investigates how physical activity and exercise impact heart rate variability, particularly in patients with obstructive sleep apnea (OSA). He explores the mechanisms behind sleep apnea, including its effects on cardiovascular diseases and how exercise can mitigate these risks. Additionally, Frederic’s research delves into the adherence to CPAP therapy (Continuous Positive Airway Pressure) for OSA patients and factors influencing patient compliance. His studies have also addressed the integrity of the blood-brain barrier in elderly patients with OSA and its broader implications on neurological health. Through his extensive work, Frederic aims to better understand the physiological adaptations in response to exercise and how these can be utilized to improve health outcomes, especially for those at risk of cardiovascular diseases and sleep-related disorders.

📚 Publilcation 

Heart rate deceleration capacity as a marker of perioperative risk: identifying relevant patient phenotypes and surgical procedures

Authors: Frederic Roche et al.

Citations: Not available yet

Year: 2024

DOI: 10.1016/j.bja.2024.07.013

“Selected” Exosomes from Sera of Elderly Severe Obstructive Sleep Apnea Patients: Their Impact on the Blood-Brain-Barrier Function

Authors: Frederic Roche et al.

Citations: Not available yet

Year: 2024

DOI: 10.20944/preprints202409.1544.v1

The PAP-RES algorithm: Defining who, why, and how to use positive airway pressure therapy for OSA

Authors: Frederic Roche et al.

Citations: Not available yet

Year: 2024

DOI: 10.1016/j.smrv.2024.101932

Early Increase in Blood–Brain Barrier Permeability in a Murine Model Exposed to Fifteen Days of Intermittent Hypoxia

Authors: Frederic Roche et al.

Citations: Not available yet

Year: 2024

DOI: 10.3390/ijms25053065

CVRanalysis: a free software for analyzing cardiac, vascular, and respiratory interactions

Authors: Frederic Roche et al.

Citations: Not available yet

Year: 2024

DOI: 10.3389/fphys.2023.1224440

Anatomy and physiology of the autonomic nervous system: Implication on the choice of diagnostic/monitoring tools

Authors: Frederic Roche et al.

Citations: Not available yet

Year: 2024

DOI: 10.1016/j.neurol.2023.12.003

The Acti-Pair program helps men with prostate cancer increase physical activity with peer support: a mixed method pilot study

Authors: Frederic Roche et al.

Citations: Not available yet

Year: 2024

DOI: 10.3389/fpubh.2023.1321230

EFAS/EAN survey on the influence of the COVID-19 pandemic on European clinical autonomic education and research

Authors: Frederic Roche et al.

Citations: Not available yet

Year: 2023

DOI: 10.1007/s10286-023-00985-3

 

 

Mariela Vanina Pace | Biochemistry | Best Researcher Award

Published on by Cognitive Scientist Awards

Mariela Vanina Pace | Biochemistry | Best Researcher Award 🏆

Doctoral student at Institute of Research in Genetic Engineering and Molecular Biology,Argentina🎓

🌟 Mariela Vanina Pace is an accomplished professional with a rich background in biochemistry, pharmacy, and molecular biology. She completed her undergraduate studies in Biochemistry with a specialization in Biotechnology at the University of Buenos Aires in 1996, earning a diploma of honor. Following this, she pursued a degree in Pharmacy at the same university, graduating in 2002. Most recently, she earned her Master’s degree in Medical Molecular Biology in 2023, with an outstanding thesis focused on genotyping mutations in patients with non-syndromic hearing loss.

 

Professional Profile 

🎓 Education

🎓 Mariela Vanina Pace has a strong educational foundation in biochemistry, pharmacy, and molecular biology, having pursued these fields at the prestigious University of Buenos Aires. She began her academic journey by earning a degree in Biochemistry with a specialization in Biotechnology from the Faculty of Pharmacy and Biochemistry in 1996, graduating with honors. Driven by a passion for medical sciences, she continued her studies and completed a degree in Pharmacy from the same faculty in 2002. Her commitment to advancing her expertise led her to pursue a Master’s in Medical Molecular Biology from 2018 to 2020, where she focused on genetic mutations linked to hearing loss. She successfully defended her thesis titled, “Genotyping of Frequent Mutations in Patients with Non-Syndromic Hearing Loss”, in May 2023, receiving an outstanding grade of 10/10.Mariela’s education reflects her dedication to both foundational sciences and advanced medical research, making her an expert in the intersection of biochemistry, pharmacy, and molecular biology.

🏢 Work Experience

💼  Mariela has extensive professional experience in clinical laboratories. She served as the Technical Director of a private clinical analysis laboratory in Vicente López from 1998 to 2021 and has worked as a biochemist in the bacteriology department. Her hands-on experience includes positions in various laboratories, both in the public and private sectors, contributing to her expertise in clinical analysis and laboratory management.

🧬 Skills

Mariela‘s scientific and technical skills span biochemistry, pharmacy, clinical analysis, and molecular biology. Her exceptional performance earned her honors throughout her education, including a 10/10 score for her master’s thesis defense. She is proficient in Spanish (native), English (B2 level), and German (A2 level).

🌍 Memberships

Along with her academic titles, she is an active member of the Russian Academy of Natural Sciences and has contributed extensively to advancing pharmacological research in Armenia and internationally.

📚 Teaching Experience

From 1992 to 1994, Mariela worked as a teaching assistant in Human Anatomy at the University of Buenos Aires, showcasing her commitment to academic development and student mentorship.

🔬 Research Focus

Her research primarily revolves around genetic mutations related to non-syndromic hearing loss, with a strong emphasis on molecular biology. She has also supervised student theses, such as a study on anemia statistics in patients with iron deficiency and chronic conditions.

 

📚 Publilcation 

Comprehensive Approach for the Genetic Diagnosis of Patients with Waardenburg Syndrome
Journal of Personalized Medicine
2024-08 | journal-article

 

 

 

Ruzanna Paronikyan | pharmacology | Best Researcher Award

Published on by Cognitive Scientist Awards

Assoc Prof Dr. Ruzanna Paronikyan | pharmacology | Best Researcher Award 🏆

pharmacologist at Scientific and Technological Center of Organic and Pharmaceutical Chemistry NAS of Armenia🎓

🌟 Ruzanna Paronikyan is a highly accomplished Doctor of Biological Sciences with a specialization in pharmacology and physiology. She completed her education at Yerevan State University in the Faculty of Biology, where she spent five years earning her diploma as a biologist and biology and chemistry teacher.

Professional Profile 

🎓 Education

Ruzanna earned her Ph.D. in 1990, specializing in pharmacology, and later, in 2021, she was awarded a Doctor of Biological Sciences degree with a focus on the physiology of humans and animals. Over the years, she has published numerous research articles in renowned journals on neurotropic drugs, anticonvulsants, and biological activity synthesis.

🏢 Work Experience

💼 Ruzanna works at the National Academy of Sciences of the Republic of Armenia, specifically in the Laboratory of Pharmacology and Histopathology, where she serves as a Leading Researcher. Her focus is on pharmacological research, particularly the synthesis and biological activities of compounds with potential anticonvulsant and psychotropic properties. She has led several significant research grants, including thematic funding from the State Committee of Science for projects from 2013-2015 and 2021-2024.

🧬 Skills

Ruzanna is skilled in experimental pharmacology, histopathology, and chemistry, particularly in synthesizing bioactive compounds. She holds the prestigious title of Academician of the Russian Academy of Natural Sciences and is a certified docent.

🌍 Memberships

Along with her academic titles, she is an active member of the Russian Academy of Natural Sciences and has contributed extensively to advancing pharmacological research in Armenia and internationally.

📚 Teaching Experience

📚 While most of her career has been in research, Ruzanna’s foundation in biology and chemistry education and her status as a certified docent indicate her involvement in teaching and mentoring young scientists, particularly in the fields of biological sciences and pharmacology.

🔬 Research Focus

🔬Her research primarily centers around the synthesis of neurotropic and anticonvulsant compounds, with a strong interest in their pharmacological properties. She has collaborated on various studies exploring how synthesized compounds affect neurological conditions, including epilepsy and other psychotropic disorders.

 

📚 Publilcation 

Title: Synthesis and Evaluation of the Neurotropic Activity of New β-Cycloketol Derivatives
Authors: Kocharov, S.L., Panosyan, H.A., Mirzoyan, L.S., Nazaryan, I.M., Paronikyan, R.G.
Journal: Pharmaceutical Chemistry Journal
Year: 2024
Citations: 0

Title: Synthesis and Psychotropic Properties of Novel Condensed Triazines for Drug Discovery
Authors: Paronikyan, E.G., Dashyan, S.S., Mamyan, S.S., Hunanyan, L.S., Hobosyan, N.G.
Journal: Pharmaceuticals
Year: 2024
Citations: 0

Title: Synthesis, Evaluation of Biological Activity and SAR of New Thioalkyl Derivatives of Pyridine
Authors: Dashyan, S., Babaev, E.V., Ayvazyan, A.G., Hunanyan, L.S., Paronikyan, R.G.
Journal: Bioorganic Chemistry
Year: 2024
Citations: 0

Title: Synthesis and Neurotropic Activity of New Derivatives of Some Amino Acid Hydantoins and Their Lithium Salts
Authors: Paronikyan, R.G., Grigoryan, A.S., Barkhudaryants, I.M., Arshakyan, L.M., Harutyunyan, A.A.
Journal: Bioactive Compounds in Health and Disease
Year: 2024
Citations: 0

Title: Synthesis and Evaluation of the Biological Activity of New Succinimides Substituted at the Nitrogen Atom with Benzenesulfonamides
Authors: Kocharov, S.L., Panosyan, H.A., Jaghatspanyan, I.A., Stepanyan, H.M., Paronikyan, R.V.
Journal: Pharmaceutical Chemistry Journal
Year: 2023
Citations: 0

Title: New Bicyclic Pyridine-Based Hybrids Linked to the 1,2,3-Triazole Unit: Synthesis via Click Reaction and Evaluation of Neurotropic Activity and Molecular Docking
Authors: Sirakanyan, S.N., Spinelli, D., Petrou, A., Arakelyan, T.A., Hovakimyan, A.A.
Journal: Molecules
Year: 2023
Citations: 2

Title: Assessing Neurotropic Effects of New Antiepileptic Nitrogen-Containing Drugs
Authors: Paronikyan, R.G., Avakyan, G.G., Avakyan, V.N., Paronikyan, E.G.
Journal: Epilepsy and Paroxysmal Conditions
Year: 2023
Citations: 1

Title: Evaluation of Neurotropic Activity and Molecular Docking Study of New Derivatives of pyrano[4″,3″:4′,5′]pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidines
Authors: Dashyan, S.Sh., Babaev, E., Paronikyan, E., Paronikyan, R., Hunanyan, L.
Journal: Molecules
Year: 2022
Citations: 2

Title: Synthesis, Neurotropic Activity, and Molecular Docking of New Condensed Thieno[2,3-b]pyridine Derivatives
Authors: Dabaeva, V.V., Baghdasaryan, M.R., Paronikyan, R.G., Paronikyan, E.G., Dashyan, S.S.
Journal: Russian Journal of Bioorganic Chemistry
Year: 2022
Citations: 2